An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Accrufer

Chemical Nameferric maltol
Dosage FormCapsule (oral; 30 mg)
Drug ClassMiscellaneous
SystemDigestive
CompanyShield Tx
Approval Year2019

Indication

  • Accrufer is indicated for the treatment of iron deficiency in adults.
Last updated on 10/29/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Accrufer (ferric maltol) Prescribing Information 2019Shield Tx
Document TitleYearSource
Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study2016Alimentary Pharmacology and Therapeutics
Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program2015Inflammatory Bowel Diseases